The ROAR trial tested the hypothesis that returning familial hypercholesterolemia-associated genetic results leads to ...

Diagnostics and imaging innovation is advancing rapidly, with new screening technologies expanding what's possible in early cancer detection. Providers need clear guidance on how to incorporate ...

A new study by the National Cancer Research Center (CNIO) has identified several sets of genes related to the predisposition ...

As prenatal genetic testing becomes more common, experts explain what these tests can and cannot predict, how parents should ...

Social media users shared a cosmic claim about an alleged secret NASA document named "Project Anchor" leaking online in 2024.

This knowledge would help identify individuals who could benefit from early detection programmes, which are essential for a ...

Nucleome Therapeutics nominates first preclinical development candidate First-in-class monoclonal antibody agonist programme for inflammation resolution with broad applicability across major chronic ...

CNIO researchers identified complement system genes linked to pancreatic cancer susceptibility and prognosis. Mutations in ...

New name reflects the Company’s strategic evolution focused on later-stage preclinical assets leveraging its most advanced, signature gene-editing capabilities Pre-IND meeting held in 4Q 2025 ...

DNA analysis of cultural artifacts shows diverse biological profiles, but contamination and mixed signals complicate ...

Enhanced Genomics (‘Enhanced’ or ‘the Company’), the biotechnology company pioneering 3D multi-omics to rapidly identify high ...

A new study by the National Cancer Research Centre (CNIO) has identified several sets of genes related to the predisposition ...